Specific phospholipids enhance the activity of β-lactam antibiotics againts Pseudomonas aeruginosa

Journal of Antimicrobial Chemotherapy

Volumn 46, Issue 3, 2000, Pages 377-384

  Krogfelt, Karen A ^a   Utley, Maryjane ^b   Krivan, Howard C ^c   Laux, David C ^b   Cohen, Paul S ^b  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY OF RHODE ISLAND   (United States)

^c Legere Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA LACTAM ANTIBIOTIC; CALCIUM; CEFTAZIDIME; CHELATING AGENT; DIPALMITOYLPHOSPHATIDYLSERINE; GLYCEROL; GLYCEROPHOSPHATE; MAGNESIUM; MONOPALMITOYLPHOSPHATIDIC ACID; PALMITIC ACID; PHOSPHOLIPID; PHOSPHOSERINE; PIPERACILLIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM ISOLATION; COLONY FORMING UNIT; CONTROLLED STUDY; CULTURE MEDIUM; CYSTIC FIBROSIS; DRUG POTENCY; DRUG POTENTIATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; SPUTUM ANALYSIS; STRAIN DIFFERENCE;

AMPICILLIN; ANTI-BACTERIAL AGENTS; CALCIUM; CULTURE MEDIA; CYSTIC FIBROSIS; DETERGENTS; ENVIRONMENTAL MICROBIOLOGY; FATTY ACIDS; HUMANS; MAGNESIUM; MICROBIAL SENSITIVITY TESTS; PENICILLINS; PHOSPHATIDYLSERINES; PHOSPHOLIPIDS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 0033828921     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Outer membrane permeability in Pseudomonas aeruginosa: Comparison of a wild-type with an antibiotic-supersusceptible mutant
2. Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane
3. Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes
4. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa
5. Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression
6. Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed β-lactamase producing strains
7. Clinical significance of β-lactamase induction and stable derepression in gram-negative rods
8. The β-lactamases of gram-negative bacteria and their possible physiological role
9. Polycations sensitize enteric bacteria to antibiotics
10. The outer membrane permeability-increasing action of deacylpolymixins
11. Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes Observations on their relationship
12. Peptides from frog skin
13. Antibacterial peptides: Key components needed in immunity
14. Cell-free immunity in cecropia. A model system for antibacterial proteins
15. Antimicrobial polypeptides of human neutrophils
16. Defensins: Endogenous antibiotic peptides of animal cells
17. The bacterial outer membrane as a drug barrier
18. Outer membrane
19. Agents that increase the permeability of the outer membrane
20. Interactions of small molecules with membranes: Partitioning, permeability, and electrical effects
21. Isolation and characterisation of an attenuated strain of Pseudomonas aeruginosa AC869, a 3,5- dichlorobenzoate degrader
22. Genetic rearrangements in plasmids specifying total degradation of chlorinated benzoic acids
23. Outer membrane of Pseudomonas aeruginosa: Heat-and 2-mercaptoethanol-modifiable proteins
24. Construction and characterisation of Pseudomonas aeruginosa protein F-deficient mutants after in vitro and in vivo insertion mutagenesis of the cloned gene
25. Restriction and nonglucosylated T-even bacteriophage: Properties of permissive mutants of Escherichia coli B and K12
26. Microdetermination of phosphorus
27. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center
28. Liposome- encapsulated antibiotics: Preparation, drug release and anti-microbial activity against Pseudomonas aeruginosa
29. Liposome encapsulation: A method for enhancing the effectiveness of local antibiotics
30. Involvement of the outer membrane in gentamicin and streptomycin uptake and killing in Pseudomonas aeruginosa
31. Resistance of Pseudomonas aeruginosa to antimicrobial drugs
32. Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia
33. Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response
34. Pseudomonas aeruginosa in isolates from patients with cystic fibrosis: A class of serum-sensitive nontypable strains deficient in lipopolysaccharide O side chains
35. Prevalence and persistence of polyagglutinable Pseudomonas aeruginosa isolates in cystic fibrosis patients